Abstract
In the last ten years, Germany has had many significant achievements supporting the implementation of Personalized Medicine in clinical practice. Thus, Personalized Medicine in Germany is not a distant future anymore. This is supported by the list of approved personalized drugs and companion tests, the introduction of the European genetics and pharmacogenetics guidelines, Personalized Medicine IT projects, as well as efforts to standardize terminology and nomenclature.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2019 Springer Fachmedien Wiesbaden GmbH, part of Springer Nature
About this chapter
Cite this chapter
Kichko, K. (2019). Further Implementation of Personalized Medicine in Germany Based on Learnings from the U.S.. In: Personalized Medicine as Innovation. Gesundheitsmanagement und Gesundheitsökonomik. Springer Gabler, Wiesbaden. https://doi.org/10.1007/978-3-658-27843-4_6
Download citation
DOI: https://doi.org/10.1007/978-3-658-27843-4_6
Published:
Publisher Name: Springer Gabler, Wiesbaden
Print ISBN: 978-3-658-27842-7
Online ISBN: 978-3-658-27843-4
eBook Packages: Economics and FinanceEconomics and Finance (R0)